170 related articles for article (PubMed ID: 15073669)
41. Helicase-primase inhibitor pritelivir for HSV-2 infection.
Wald A; Corey L; Timmler B; Magaret A; Warren T; Tyring S; Johnston C; Kriesel J; Fife K; Galitz L; Stoelben S; Huang ML; Selke S; Stobernack HP; Ruebsamen-Schaeff H; Birkmann A
N Engl J Med; 2014 Jan; 370(3):201-10. PubMed ID: 24428466
[TBL] [Abstract][Full Text] [Related]
42. Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals. Collaborative Famciclovir HIV Study Group.
Romanowski B; Aoki FY; Martel AY; Lavender EA; Parsons JE; Saltzman RL
AIDS; 2000 Jun; 14(9):1211-7. PubMed ID: 10894286
[TBL] [Abstract][Full Text] [Related]
43. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir.
Wald A; Zeh J; Barnum G; Davis LG; Corey L
Ann Intern Med; 1996 Jan; 124(1 Pt 1):8-15. PubMed ID: 7503497
[TBL] [Abstract][Full Text] [Related]
44. [Genital herpes: epidemiology, transmission, clinic, asymptomatic viral excretion, impact on other sexually transmitted diseases, prevention, and treatment].
Bossi P
Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):477-93. PubMed ID: 12122319
[TBL] [Abstract][Full Text] [Related]
45. Safety of famciclovir in patients with herpes zoster and genital herpes.
Saltzman R; Jurewicz R; Boon R
Antimicrob Agents Chemother; 1994 Oct; 38(10):2454-7. PubMed ID: 7840587
[TBL] [Abstract][Full Text] [Related]
46. Management of genital herpes.
Mertz GJ
Adv Exp Med Biol; 1996; 394():1-10. PubMed ID: 8815676
[TBL] [Abstract][Full Text] [Related]
47. Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial.
Shafran SD; Tyring SK; Ashton R; Decroix J; Forszpaniak C; Wade A; Paulet C; Candaele D
J Clin Virol; 2004 Apr; 29(4):248-53. PubMed ID: 15018852
[TBL] [Abstract][Full Text] [Related]
48. Single-dose famciclovir for the treatment of herpes labialis.
Hull C; Spruance S; Tyring S; Hamed K
Curr Med Res Opin; 2006 Sep; 22(9):1699-702. PubMed ID: 16968573
[TBL] [Abstract][Full Text] [Related]
49. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
Gupta R; Wald A; Krantz E; Selke S; Warren T; Vargas-Cortes M; Miller G; Corey L
J Infect Dis; 2004 Oct; 190(8):1374-81. PubMed ID: 15378428
[TBL] [Abstract][Full Text] [Related]
50. A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery.
Watts DH; Brown ZA; Money D; Selke S; Huang ML; Sacks SL; Corey L
Am J Obstet Gynecol; 2003 Mar; 188(3):836-43. PubMed ID: 12634667
[TBL] [Abstract][Full Text] [Related]
51. Famciclovir effective in suppressing recurrent genital herpes.
AIDS Patient Care STDS; 1996 Apr; 10(2):130. PubMed ID: 11361692
[No Abstract] [Full Text] [Related]
52. Antiviral drug reduces shedding of herpes virus.
Newsline People AIDS Coalit N Y; 1998 Feb; ():36. PubMed ID: 11367447
[TBL] [Abstract][Full Text] [Related]
53. Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus-infected subjects.
DeJesus E; Wald A; Warren T; Schacker TW; Trottier S; Shahmanesh M; Hill JL; Brennan CA;
J Infect Dis; 2003 Oct; 188(7):1009-16. PubMed ID: 14513421
[TBL] [Abstract][Full Text] [Related]
54. Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial.
Mark KE; Corey L; Meng TC; Magaret AS; Huang ML; Selke S; Slade HB; Tyring SK; Warren T; Sacks SL; Leone P; Bergland VA; Wald A
J Infect Dis; 2007 May; 195(9):1324-31. PubMed ID: 17397003
[TBL] [Abstract][Full Text] [Related]
55. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
Fife KH; Warren TJ; Justus SE; Heitman CK;
Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
[TBL] [Abstract][Full Text] [Related]
56. Efficacy of famciclovir in the treatment of herpes zoster.
Tyring SK
Semin Dermatol; 1996 Jun; 15(2 Suppl 1):27-31. PubMed ID: 8840413
[TBL] [Abstract][Full Text] [Related]
57. Detection of viral DNA to evaluate outcome of antiviral treatment of patients with recurrent genital herpes.
Diaz-Mitoma F; Ruben M; Sacks S; MacPherson P; Caissie G
J Clin Microbiol; 1996 Mar; 34(3):657-63. PubMed ID: 8904433
[TBL] [Abstract][Full Text] [Related]
58. Frequency of asymptomatic shedding of herpes simplex virus in women with genital herpes.
Brock BV; Selke S; Benedetti J; Douglas JM; Corey L
JAMA; 1990 Jan; 263(3):418-20. PubMed ID: 2152951
[TBL] [Abstract][Full Text] [Related]
59. Effect of resiquimod 0.01% gel on lesion healing and viral shedding when applied to genital herpes lesions.
Fife KH; Meng TC; Ferris DG; Liu P
Antimicrob Agents Chemother; 2008 Feb; 52(2):477-82. PubMed ID: 18039918
[TBL] [Abstract][Full Text] [Related]
60. Genital herpes simplex virus and its treatment: focus on famciclovir.
Sacks SL
Semin Dermatol; 1996 Jun; 15(2 Suppl 1):32-6. PubMed ID: 8840414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
